Log in

NASDAQ:OFIXOrthofix Medical Stock Price, Forecast & News

+0.34 (+0.98 %)
(As of 06/3/2020 04:00 PM ET)
Today's Range
Now: $34.91
50-Day Range
MA: $33.77
52-Week Range
Now: $34.91
Volume187,567 shs
Average Volume161,259 shs
Market Capitalization$670.27 million
P/E RatioN/A
Dividend YieldN/A
Orthofix Medical Inc., a medical device company, provides musculoskeletal healing products and therapies worldwide. It operates through four segments: Bone Growth Therapies, Spinal Implants, Biologics, and Orthofix Extremities. The Bone Growth Therapies segment manufactures, distributes, and provides support services for bone growth stimulator devices that enhance bone fusion and are indicated as treatment to enhance fusion success rates in cervical and lumbar spine, as well as a therapeutic treatment for non-spinal appendicular fractures. The Spinal Implants segment designs, develops, and markets a portfolio of implant products used in surgical procedures of the spine. The Biologics segment provides a portfolio of regenerative products and tissue forms that allow physicians to treat a range of spinal and orthopedic conditions. The Orthofix Extremities segment designs, develops, and markets orthopedic products used in fracture repair, deformity correction, and bone reconstruction procedures. The company markets and distributes its products through direct sales representatives; independent distributors; and employed and independent sales representatives to physicians, hospitals, ambulatory surgery centers, integrated health delivery systems, and other purchasing organizations. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in July 2018. Orthofix Medical Inc. was founded in 1987 and is headquartered in Lewisville, Texas.
Read More
Orthofix Medical logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.3Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 4.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

2.04 out of 5 stars

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryHealth Care Equipment
Current SymbolNASDAQ:OFIX



Sales & Book Value

Annual Sales$459.95 million
Cash Flow$3.02 per share
Book Value$17.22 per share


Net Income$-28,460,000.00


Market Cap$670.27 million
Next Earnings Date8/3/2020 (Estimated)

Receive OFIX News and Ratings via Email

Sign-up to receive the latest news and ratings for OFIX and its competitors with MarketBeat's FREE daily newsletter.

Orthofix Medical (NASDAQ:OFIX) Frequently Asked Questions

How has Orthofix Medical's stock been impacted by COVID-19 (Coronavirus)?

Orthofix Medical's stock was trading at $30.67 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, OFIX shares have increased by 13.8% and is now trading at $34.91. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Orthofix Medical?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Orthofix Medical in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Orthofix Medical.

When is Orthofix Medical's next earnings date?

Orthofix Medical is scheduled to release its next quarterly earnings announcement on Monday, August 3rd 2020. View our earnings forecast for Orthofix Medical.

How were Orthofix Medical's earnings last quarter?

Orthofix Medical Inc (NASDAQ:OFIX) issued its quarterly earnings data on Friday, May, 8th. The medical device company reported $0.09 earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of $0.11 by $0.02. The medical device company had revenue of $104.82 million for the quarter, compared to analyst estimates of $104.50 million. Orthofix Medical had a negative net margin of 0.81% and a positive return on equity of 7.46%. View Orthofix Medical's earnings history.

What guidance has Orthofix Medical issued on next quarter's earnings?

Orthofix Medical updated its first quarter 2020 Pre-Market earnings guidance on Thursday, April, 9th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $104-105 million, compared to the consensus revenue estimate of $106.54 million.

What price target have analysts set for OFIX?

2 analysts have issued 1-year price targets for Orthofix Medical's shares. Their forecasts range from $42.00 to $56.00. On average, they anticipate Orthofix Medical's share price to reach $49.00 in the next year. This suggests a possible upside of 40.4% from the stock's current price. View analysts' price targets for Orthofix Medical.

Has Orthofix Medical been receiving favorable news coverage?

News articles about OFIX stock have trended somewhat negative on Thursday, InfoTrie Sentiment reports. The research firm scores the sentiment of media coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Orthofix Medical earned a news sentiment score of -1.4 on InfoTrie's scale. They also assigned news coverage about the medical device company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the stock's share price in the immediate future. View the latest news aboutOrthofix Medical.

Are investors shorting Orthofix Medical?

Orthofix Medical saw a increase in short interest in the month of May. As of May 15th, there was short interest totaling 352,100 shares, an increase of 47.4% from the April 30th total of 238,900 shares. Based on an average daily trading volume, of 179,600 shares, the short-interest ratio is currently 2.0 days. Approximately 1.9% of the shares of the company are short sold. View Orthofix Medical's Current Options Chain.

Who are some of Orthofix Medical's key competitors?

What other stocks do shareholders of Orthofix Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Orthofix Medical investors own include AbbVie (ABBV), Enterprise Products Partners (EPD), Gilead Sciences (GILD), Exxon Mobil (XOM), Allergan (AGN), Biogen (BIIB), Clovis Oncology (CLVS), Esperion Therapeutics (ESPR), Edwards Lifesciences (EW) and Intercept Pharmaceuticals (ICPT).

Who are Orthofix Medical's key executives?

Orthofix Medical's management team includes the following people:
  • Mr. Bradley R. Mason, Pres, CEO & Director (Age 65)
  • Mr. Douglas C. Rice, CFO & Chief Accounting Officer (Age 53)
  • Ms. Kimberley A. Elting, Chief Legal & Admin. Officer (Age 54)
  • Mr. Michael M. Finegan, Chief Strategy Officer (Age 55)
  • Mr. Davide Bianchi, Pres of Global Extremities (Age 54)

What is Orthofix Medical's stock symbol?

Orthofix Medical trades on the NASDAQ under the ticker symbol "OFIX."

Who are Orthofix Medical's major shareholders?

Orthofix Medical's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (15.13%), Paradice Investment Management LLC (5.49%), Paradice Investment Management LLC (5.49%), State Street Corp (3.69%), Morgan Stanley (2.61%) and Morgan Stanley (2.61%). Company insiders that own Orthofix Medical stock include Brad Mason, Bradley V Niemann, Davide Bianchi, James F Hinrichs, Jon Carl Serbousek, Kimberley A Elting, Luke T Faulstick, Rice Doug and Ronald A Matricaria. View institutional ownership trends for Orthofix Medical.

Which institutional investors are selling Orthofix Medical stock?

OFIX stock was sold by a variety of institutional investors in the last quarter, including Rothschild & Co. Asset Management US Inc., BlackRock Inc., Dalton Greiner Hartman Maher & Co., Deutsche Bank AG, AJO LP, THB Asset Management, Federated Hermes Inc., and Wells Fargo & Company MN. View insider buying and selling activity for Orthofix Medical.

Which institutional investors are buying Orthofix Medical stock?

OFIX stock was purchased by a variety of institutional investors in the last quarter, including Morgan Stanley, Morgan Stanley, Paradice Investment Management LLC, Paradice Investment Management LLC, JPMorgan Chase & Co., Polar Asset Management Partners Inc., Bogle Investment Management L P DE, and SG Americas Securities LLC. Company insiders that have bought Orthofix Medical stock in the last two years include James F Hinrichs, Jon Carl Serbousek, and Ronald A Matricaria. View insider buying and selling activity for Orthofix Medical.

How do I buy shares of Orthofix Medical?

Shares of OFIX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Orthofix Medical's stock price today?

One share of OFIX stock can currently be purchased for approximately $34.91.

How big of a company is Orthofix Medical?

Orthofix Medical has a market capitalization of $670.27 million and generates $459.95 million in revenue each year. The medical device company earns $-28,460,000.00 in net income (profit) each year or $1.47 on an earnings per share basis. Orthofix Medical employs 1,055 workers across the globe.

What is Orthofix Medical's official website?

The official website for Orthofix Medical is www.orthofix.com.

How can I contact Orthofix Medical?

Orthofix Medical's mailing address is 3451 Plano Parkway, Lewisville TX, 75056. The medical device company can be reached via phone at 214-937-2000 or via email at [email protected]

This page was last updated on 6/4/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.